Jan 16, 2020 (AmericaNewsHour) -- Market Study Report adds new research on Cannabis market, which is a detailed analysis of this business space inclusive of the trends, competitive landscape, and the market size. Encompassing one or more parameters among product analysis, application potential, and the regional growth landscape, Cannabis market also includes an in-depth study of the industrys competitive scenario.
The global cannabis market is expected to reach US$ 153,689.9 Mn in 2027 from US$ 10,838.1 in 2018. The market is estimated to grow with a CAGR of 34.5% from 2019-2027.
The key factors such as increasing number of countries decriminalizing the use of cannabis and legalizing the cannabis for medical use, increasing awareness of benefits offered by cannabis through conduction of workshops and symposiums and increasing technological development in the field of medical cannabis is expected to account for the growth of the global cannabis market. In recent years the whole, unprocessed marijuana plant or its basic extracts are used to treat symptoms of illness and other medical conditions. The US FDA has not approved marijuana plant as medicine but certain chemicals from the plant called cannabinoids, are FDA-approved medications which are in the form of pill. As cannabis helps in treating certain illnesses and symptoms many regions/countries have legalized marijuana for medical use. Currently the two cannabinoids from the marijuana plant that are of medical interest are tetrahydrocannabinol (THC) and cannabidiol (CBD).
Request a sample of this premium report at https://www.marketstudyreport.com/request-a-sample/2202058?utm_source=marketwatch.com&utm_medium=Abhijeet
Cannabis Market Key Company Profiles
Cannabis Science, INC.
Canopy Growth Corporation
Medical Marijuana, Inc.
VIVO Cannabis Inc.
Terra Tech Corp.
The Cronos Group
THC may also decrease pain, inflammation (swelling and redness), and muscle control problems. CBD is used to reduce pain, inflammation, control epileptic seizures, and to treat mental illness and addictions. The FDA approved a CBD-based liquid medication called Epidiolex for the treatment of two forms of severe childhood epilepsy, Dravet syndrome and Lennox-Gastaut syndrome. A few studies have reported that inhaled (smoked or vaporized) marijuana can be helpful treatment of neuropathic pain (pain caused by damaged nerves). Thus growing medicinal applications of cannabis in diseases like HIV, epilepsy and others is expected to drive cannabis market during the forecast period.
The global cannabis market based on the application was segmented into medical and recreational uses. In 2018, the medical segment held the largest share of the market, by application. However, the recreational segmented is anticipated to witness fastest growth in the cannabis market, based on application.
Some of the major primary and secondary sources included in the report for the Cannabis Market are the World Health Organization, European Observatory on Cannabis Cultivation, Centers for Disease Control and Prevention, Organisation for Economic Co-operation and Development, National Center for Biotechnology Information, Medical Marijuana Regulation and Safety Act, Drug Enforcement Administration, and others.
Request a discount on standard prices of this premium report at https://www.marketstudyreport.com/check-for-discount/2202058?utm_source=marketwatch.com&utm_medium=Abhijeet
TABLE OF CONTENTS
2. Global Cannabis Market Key Takeaways
3. Research Methodology
4. Global Cannabis Market Landscape